{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-5978", "FDA", "Requests that the FDA declare that Cyproheptadine HCL Tablets, 3 mg and 6 mg, are suitable for submission as an ANDA", "Nonrulemaking", "2026-06-15T18:40:48Z", "0b000064b92f3694"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-5978"], "units": {}, "query_ms": 0.15627399261575192, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}